Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Inhibitor development in non-severe haemophilia across Europe.

Fischer K, Iorio A, Lassila R, Peyvandi F, Calizzani G, Gatt A, Lambert T, Windyga J, Gilman EA, Hollingsworth R, Makris M; EUHASS Participants.

Thromb Haemost. 2015 Oct;114(4):670-5. doi: 10.1160/TH14-12-1044. Epub 2015 Aug 13. Erratum in: Thromb Haemost. 2016 Mar;115(3):684. Hollingsworth, R [Added].

PMID:
26293381
2.

Clinical characteristics and course of patients with diabetes entering cardiac rehabilitation.

Giallauria F, Fattirolli F, Tramarin R, Ambrosetti M, Griffo R, Riccio C, De Feo S, Piepoli MF, Vigorito C; ISYDE-2008 Investigators of Italian Association for Cardiovascular Prevention, Rehabilitation (GICR-IACPR).

Diabetes Res Clin Pract. 2015 Feb;107(2):267-72. doi: 10.1016/j.diabres.2014.11.006. Epub 2014 Dec 3.

PMID:
25497465
3.

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors.

Coppola A, Margaglione M, Santagostino E, Rocino A, Grandone E, Mannucci PM, Di Minno G; AICE PROFIT Study Group.

J Thromb Haemost. 2009 Nov;7(11):1809-15. doi: 10.1111/j.1538-7836.2009.03615.x. Epub 2009 Sep 9.

Supplemental Content

Loading ...
Support Center